Daniella Beckman

Insider Reports History

Location
C/O Idenix Pharmaceuticals, Inc., One Kendall Square, Bldg. 1400, Cambridge, MA
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniella Beckman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Chief Financial Officer Common Stock 150K $475K $3.16 Feb 5, 2025 Direct
Blueprint Medicines Corp Director Common Stock 0 $0 $101.84 Jul 17, 2025 Direct
Tango Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 157K Feb 3, 2025 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30K May 22, 2025 Direct
Upstream Bio, Inc. Director Stock Option (Right to Buy) 17.1K Jun 10, 2025 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 0 Jul 17, 2025 Direct
Translate Bio, Inc. Director Stock Option (right to buy) 0 Sep 14, 2021 Direct

Insider Reports Filed by Daniella Beckman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jul 17, 2025 6 $0 4 Jul 21, 2025 Director
BPMC Blueprint Medicines Corp Jun 18, 2025 1 $500K 4 Jun 24, 2025 Director
UPB Upstream Bio, Inc. Jun 10, 2025 1 $0 4 Jun 12, 2025 Director
VOR Vor Biopharma Inc. May 22, 2025 1 $0 4 May 23, 2025 Director
TNGX Tango Therapeutics, Inc. Feb 4, 2025 2 -$25.3K 4 Feb 6, 2025 Chief Financial Officer
TNGX Tango Therapeutics, Inc. Feb 3, 2025 2 $0 4 Feb 5, 2025 Chief Financial Officer
UPB Upstream Bio, Inc. Oct 10, 2024 1 $0 4 Oct 15, 2024 Director
UPB Upstream Bio, Inc. Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
TNGX Tango Therapeutics, Inc. Feb 6, 2024 2 -$46.9K 4 Feb 8, 2024 Chief Financial Officer
TNGX Tango Therapeutics, Inc. Feb 1, 2024 2 $0 4 Feb 5, 2024 Chief Financial Officer
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director
TNGX Tango Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 2, 2023 Chief Financial Officer
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
TNGX Tango Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Financial Officer
BPMC Blueprint Medicines Corp Dec 8, 2021 2 $0 4/A Mar 31, 2022 Director
BPMC Blueprint Medicines Corp Dec 8, 2021 0 $0 3/A Mar 31, 2022 Director
TBIO Translate Bio, Inc. Sep 14, 2021 4 $0 4 Sep 14, 2021 Director
TNGX Tango Therapeutics, Inc. Aug 12, 2021 1 $0 4 Aug 16, 2021 Chief Financial Officer
TNGX Tango Therapeutics, Inc. Aug 10, 2021 0 $0 3 Aug 12, 2021 Chief Financial Officer
TBIO Translate Bio, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director